These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 359347)

  • 1. [Creation of synthetic serine proteinase inhibitors, an important pharmacological problem].
    Markwardt F
    Farmakol Toksikol; 1978; 41(5):530-3. PubMed ID: 359347
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteinases in cardiac and skeletal muscle.
    Bird JW; Carter JH; Triemer RE; Brooks RM; Spanier AM
    Fed Proc; 1980 Jan; 39(1):20-5. PubMed ID: 6985869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CU-2010--a novel small molecule protease inhibitor with antifibrinolytic and anticoagulant properties.
    Dietrich W; Nicklisch S; Koster A; Spannagl M; Giersiefen H; van de Locht A
    Anesthesiology; 2009 Jan; 110(1):123-30. PubMed ID: 19104179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complement inhibitors and their action mechanism].
    Takada A; Takada Y
    Nihon Rinsho; 1979 May; 37(5):977-82. PubMed ID: 381729
    [No Abstract]   [Full Text] [Related]  

  • 5. The multicatalytic proteinase complex.
    Rivett AJ
    Revis Biol Celular; 1989; 20():113-23. PubMed ID: 2700095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological content of hyperproteolytic states in blood by synthetic inhibitors of serine proteinases.
    Markwardt F
    Haemostasis; 1978; 7(2-3):177-82. PubMed ID: 658778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
    De Francesco R; Pessi A; Steinkühler C
    Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate variants versus transition state analogues as noncovalent reversible enzyme inhibitors.
    Smyth TP
    Bioorg Med Chem; 2004 Aug; 12(15):4081-8. PubMed ID: 15246086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High-molecular prolylendopeptidase of human erythrocytes].
    Alekseenko LP; Gol'dina OA; Orekhovich VN
    Dokl Akad Nauk SSSR; 1983; 268(1):234-8. PubMed ID: 6337797
    [No Abstract]   [Full Text] [Related]  

  • 10. Protease inhibitors in carcinogenesis: possible sites of action.
    Rossman TG; Troll W
    Carcinog Compr Surv; 1980; 5():127-43. PubMed ID: 6992994
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of a processing protease that converts the precursor form of gamma-glutamyltranspeptidase to its subunits.
    Kuno T; Matsuda Y; Katunuma N
    Biochem Int; 1984 Apr; 8(4):581-8. PubMed ID: 6148085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel series of potent and selective small molecule inhibitors of the complement component C1s.
    Subasinghe NL; Ali F; Illig CR; Jonathan Rudolph M; Klein S; Khalil E; Soll RM; Bone RF; Spurlino JC; DesJarlais RL; Crysler CS; Cummings MD; Morris PE; Kilpatrick JM; Sudhakara Babu Y
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3043-7. PubMed ID: 15149641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synthetic serin protease inhibitors. 1. Inhibition of trypsin, plasmin and thrombin by amidino- and guanidinobenzoic acid esters].
    Markwardt F; Walsmann P; Stürzebecher J; Landmann H; Wagner G
    Pharmazie; 1973 May; 28(5):326-30. PubMed ID: 4715051
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence that proteases are involved in superoxide production by human polymorphonuclear leukocytes and monocytes.
    Kitagawa S; Takaku F; Sakamoto S
    J Clin Invest; 1980 Jan; 65(1):74-81. PubMed ID: 6243143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bauhinia Kunitz-type proteinase inhibitors: structural characteristics and biological properties.
    Oliva ML; Sampaio UM
    Biol Chem; 2008 Aug; 389(8):1007-13. PubMed ID: 18754727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mode of action of proteinase inhibitors (Trasylol) in intracranial hemorrhages].
    Koos W; Kraus H; Blümel G; Böck F
    Neurochirurgie; 1970 Nov; 16(6):548-50. PubMed ID: 5312883
    [No Abstract]   [Full Text] [Related]  

  • 17. [Kinin system and fibrinolysis enzymatic study of the blood plasma in laryngeal cancer].
    Goloborod'ko OP; Opanashchenko GA; Kostiuchenko ES
    Zh Ushn Nos Gorl Bolezn; 1980; 1():23-6. PubMed ID: 6987818
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of proteinase/antiproteinase inhibitor disequilibrium in the bioincompatibility induced by artificial surfaces.
    Deppisch R; Haug U; Göhl H; Ritz E
    Nephrol Dial Transplant; 1994; 9 Suppl 3():17-23. PubMed ID: 7521027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray structures of five renin inhibitors bound to saccharopepsin: exploration of active-site specificity.
    Cronin NB; Badasso MO; J Tickle I; Dreyer T; Hoover DJ; Rosati RL; Humblet CC; Lunney EA; Cooper JB
    J Mol Biol; 2000 Nov; 303(5):745-60. PubMed ID: 11061973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the secretory leukocyte protease inhibitor on leukocyte proteases released during phagocytosis.
    Axelsson L; Linder C; Ohlsson K; Rosengren M
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():89-93. PubMed ID: 2578013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.